Concepedia

David Chéreau

DC

13

Publications

1.3K

Citations

13

H-Index

2000

Active since

Affiliations

Boston Biomedical Research Institute(Current)

Sunesis (United States)

University of Pennsylvania

Idera Pharmaceuticals (United States)

Yale University

David Chéreau is an author at Boston Biomedical Research Institute specializing in medicine, cell biology, and natural sciences.

Top concepts

MedicineCell BiologyNatural SciencesMolecular BiologyCytoskeletonCell MotilityCell SignalingSignal TransductionCellular BiochemistryCell Physiology

Publications per year

2000–2011

13

Publications

13

Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System

Kelly J. Inglis, David Chéreau, Elizabeth Brigham et al. · Journal of Biological Chemistry · 2008 · 266 citations · Full text

Neurodegenerative Diseases, Serine 129, Molecular Neuroscience +12

Actin-bound structures of Wiskott–Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly

David Chéreau, Frédéric Kerff, Philip Graceffa et al. · Proceedings of the National Academy of Sciences · 2005 · 258 citations · Full text

Protein Assembly, Molecular Biology, Cytoskeleton +20

Leiomodin Is an Actin Filament Nucleator in Muscle Cells

David Chéreau, Małgorzata Boczkowska, Aneta Skwarek‐Maruszewska et al. · Science · 2008 · 249 citations · Full text

Muscle Physiology, Muscle Cells, Molecular Physiology +15

Structural Basis for the Actin-Binding Function of Missing-in-Metastasis

Sung Haeng Lee, Frédéric Kerff, David Chéreau et al. · Structure · 2007 · 151 citations · Full text

Structural Basis, Cytoskeleton, Cell Motility +4

Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-Synuclein

Katerina Levitan, David Chéreau, Samuel I. A. Cohen et al. · Journal of Molecular Biology · 2011 · 102 citations

Profound Influence, Biochemistry, Natural Sciences +4

Rows per page

1–5 of 13